Venture capital firm
Oak HC/FT portfolio
oakhcft.comOak HC/FT is a venture capital firm based in Stamford, United States, founded in 2014. It has invested in 106 venture-backed companies across 147 funding rounds on VCMC, and led 69 of those rounds. 13 of them were in the last 12 months.
106
Venture-backed companies
in its portfolio on VCMC
147
Funding rounds
led 69
13
Last 12 months
rounds, Oct 2025 to Sep 2026
30
With a disclosed valuation
of 106 companies
$87.2B
Combined value of its private companies
the whole companies, not what Oak HC/FT owns
103 private companies Oak HC/FT has backed have a VCMC valuation; together they are worth $87.2B. That is the value of the whole companies, not what Oak HC/FT owns. Devoted Health is 21% of the total. 3 companies it backed have since been acquired and are not included. How VCMC values companies.
Values cover private companies only; public companies are not included.
Portfolio
Oak HC/FT's most valuable portfolio companies
The 10 most valuable private companies Oak HC/FT has backed, by VCMC's valuation. Values cover private companies only; public companies are not included.
- 1 Devoted Health Insurance - Agents, Carriers & Brokers, Eagan $18.0B range $11.5B – $20.8B Joined at Series B, 2018
- 2 Rapyd Payment Processing & Point of Sale, Tel Aviv $4.8B range $3.1B – $5.8B Led at Series C, 2019
- 3 Olive Tech Companies $3.6B range $348M – $6.0B Joined at Growth, 2020
- 4 Health Care Services, Nashville $2.7B range $531M – $6.2B Joined at Growth, 2023
- 5 Tech Companies, Coímbra $2.7B range $1.7B – $3.1B Led at Series B, 2015
- 6 Home Health Care, Troy $2.6B range $727M – $4.0B Joined at Growth, 2024
- 7 Noom Nutritionists & Weight Loss Specialists, Princeton $2.4B range $263M – $7.5B Joined at Series F, 2021
- 8 Maven Clinic Health Care Services, New York $2.3B range $1.2B – $2.6B Led at Series B, 2018
- 9 Cart.com Tech Companies, Houston $2.0B range $1.4B – $3.0B Led at Series B, 2021
- 10 Tech Companies, New York $2.0B range $330M – $5.4B Joined at Series C, 2020
Portfolio
Full Oak HC/FT portfolio (106 companies)
106 companies. Load more shows the rest.
| # | Last round | History | Range | Trend | Grade | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Devoted Health Insurance - Agents, Carriers & Brokers · since Series B, 2018 | Series F Nov 2025 $48M | $18.0B | $11.5B – $20.8B | $18.1B (+1%) | $2.0B | 0% | 2,371 | up | A | |
| 2 | Rapyd Payment Processing & Point of Sale · led at Series C, 2019 | Growth Equity Feb 2025 $500M | $4.8B | $3.1B – $5.8B | $4.4B (-7%) | $560M | 19% | 857 | up | B | |
| 3 | Clearco Loans & Financing · led at Series C, 2021 | Debt Aug 2026 $100M | $336M | $113M – $1.4B | $231M (-31%) | $101M | 84% | 143 | down | D | |
| 4 | Olive Tech Companies · since Growth, 2020 | Series H Jul 2021 $400M | $3.6B | $348M – $6.0B | $3.5B (-4%) | $572M | 20% | 660 | unknown | D | |
| 5 | Cart.com Tech Companies · led at Series B, 2021 | Growth Equity Mar 2026 $180M | $2.0B | $1.4B – $3.0B | $2.1B (+3%) | $190M | 0% | 880 | up | B | |
| 6 | DispatchHealth Home Health Care · since Series C, 2020 | Growth Equity Nov 2022 $259M | $719M | $312M – $3.3B | $532M (-26%) | $277M | 97% | 958 | down | D | |
| 7 | Noom Nutritionists & Weight Loss Specialists · since Series F, 2021 | Series F May 2021 $540M | $2.4B | $263M – $7.5B | $2.2B (-7%) | $684M | 30% | 1,200 | flat | D | |
| 8 | Clara Payment Processing & Point of Sale · since Series A, 2021 | Debt Feb 2026 $150M | $841M | $464M – $1.2B | $822M (-2%) | $93.7M | 6% | 687 | up | B | |
| 9 | Paxos Cryptocurrency · led at Series D, 2021 | Series D Apr 2021 $300M | $1.6B | $342M – $3.9B | $1.5B (-9%) | $420M | 31% | 325 | up | D | |
| 10 | VillageMD Clinics - Surgeons & Physicians · led at Series A, 2015 | Growth Equity Jul 2020 $275M | $590M | $193M – $2.1B | $590M (0%) | $271M | 82% | 1,644 | down | D | |
| 11 | Cerebral Psychologists & Counseling Services · led at Series A, 2020 | Series C Dec 2021 $300M | $1.9B | $313M – $6.5B | $1.8B (-4%) | $686M | 46% | 580 | flat | D | |
| 12 | Maven Clinic Health Care Services · led at Series B, 2018 | Series F Oct 2024 $125M | $2.3B | $1.2B – $2.6B | $1.9B (-15%) | $248M | 0% | 1,197 | up | B | |
| 13 | Jerry Insurance - Agents, Carriers & Brokers · since Series B, 2021 | Series C Aug 2021 $75M | $475M | $188M – $1.1B | $438M (-8%) | $105M | 39% | 401 | growing | C | |
| 14 | Tech Companies · led at Series C, 2025 | Series C Jul 2025 $243M | $1.8B | $1.1B – $2.0B | $1.8B (0%) | $193M | 0% | 261 | growing | A | |
| 15 | Tech Companies · since Series B, 2025 | Series C Aug 2026 $100M | $1.0B | $869M – $1.5B | $1.3B (+24%) | $143M | 0% | 221 | growing | A | |
| 16 | Tech Companies · led at Series B, 2021 | Growth Equity May 2026 $40M | $462M | $292M – $744M | $489M (+6%) | $44.0M | 0% | 61 | unknown | B | |
| 17 | Tech Companies · led at Series C, 2025 | Series D Jul 2026 $120M | $1.2B | $801M – $2.1B | $1.5B (+22%) | $162M | 0% | 3 | unknown | B | |
| 18 | Tech Companies · led at Seed, 2013 | Series C Mar 2021 $150M | $499M | $156M – $3.3B | $451M (-10%) | $257M | 97% | 409 | down | D | |
| 19 | Tech Companies · led at Series B, 2020 | Series C Feb 2024 $100M | $1.0B | $214M – $1.8B | $855M (-18%) | $129M | 15% | 410 | flat | D | |
| 20 | Tech Companies · led at Series D, 2025 | Series D Aug 2025 $122M | $914M | $503M – $1.3B | $914M (0%) | $101M | 0% | 179 | growing | B | |
| 21 | Tech Companies · led at Series A, 2021 | Growth Equity Feb 2024 $65M | $832M | $272M – $1.2B | $605M (-27%) | $74.9M | 0% | 344 | up | C | |
| 22 | Tech Companies · since Series C, 2022 | Series C Jan 2022 $100M | $191M | $36.9M – $867M | $181M (-5%) | $71.3M | 66% | 430 | down | D | |
| 23 | Tech Companies · led at Series C, 2022 | Series C Mar 2022 $66M | $191M | $31.4M – $732M | $182M (-5%) | $54.8M | 59% | 96 | flat | D | |
| 24 | Tech Companies · led at Series B, 2026 | Series B Apr 2026 $50M | $393M | $231M – $697M | $491M (+25%) | $54.1M | 0% | 151 | growing | B | |
| 25 | Pediatrists · since Series B, 2025 | Series B Sep 2025 $67M | $718M | $298M – $1.1B | $718M (0%) | $79.0M | 0% | 230 | unknown | C | |
| 26 | Tech Companies · led at Series A, 2019 | Series B Sep 2021 $42M | $171M | $16.8M – $401M | $158M (-8%) | $42.4M | 28% | 120 | flat | D | |
| 27 | Tech Companies · led at Series A, 2018 | Series A Sep 2018 $41M | $55.7M | $12.7M – $303M | $54.6M (-2%) | $56.7M | 73% | 12 | flat | D | |
| 28 | Tech Companies · since Series A, 2022 | Series A Sep 2022 $40M | $374M | $33.7M – $720M | $364M (-3%) | $68.3M | 0% | 59 | up | D | |
| 29 | Insurance - Agents, Carriers & Brokers · led at Series B, 2015 | Series B Oct 2015 $31M | $151M | $13.1M – $320M | $151M (0%) | $36.5M | 15% | 132 | flat | D | |
| 30 | Tech Companies · led at Series A, 2026 | Series A Oct 2026 $31M | $178M | $116M – $485M | $319M (+80%) | $44.7M | 0% | 74 | growing | C | |
| 31 | Tech Companies · since Series A, 2021 | Series A Sep 2021 $20M | $118M | $9.23M – $262M | $105M (-11%) | $33.0M | 25% | 151 | flat | D | |
| 32 | Tech Companies · since Series C, 2020 | Series C Feb 2020 $15M | $77.7M | $7.22M – $197M | $77.7M (0%) | $19.5M | 20% | 231 | flat | D | |
| 33 | Aerospace and Defence · since Seed, 2022 | Seed Nov 2022 $20M | $120M | $14.2M – $283M | $110M (-9%) | $42.2M | 28% | 51 | up | D | |
| 34 | Tech Companies · since Seed, 2021 | Series A Jul 2023 $3.7M | $18.6M | $3.37M – $64.1M | $15.8M (-15%) | $5.08M | 70% | 22 | down | D | |
| 35 | Tech Companies · since Seed, 2024 | Seed Dec 2024 $10M | $140M | $34.1M – $214M | $140M (0%) | $25.3M | 0% | 19 | up | C | |
| 36 | Payment Processing & Point of Sale · since Seed, 2025 | Seed Jun 2025 $9.1M | $121M | $32.3M – $185M | $121M (0%) | $21.8M | 0% | 8 | unknown | C | |
| 37 | Payment Processing & Point of Sale · since Seed, 2022 | Seed Apr 2022 $4.0M | $32.8M | $2.78M – $42.7M | $31.4M (-4%) | $8.78M | 0% | 65 | up | D | |
| 38 | Loans & Financing · since Seed, 2020 | Other Apr 2026 $16M | $1.9B | $282M – $4.2B | $1.7B (-7%) | $373M | 34% | 428 | flat | D | |
| 39 | Medical Supply Manufacturers · since Series F, 2020 | Series G Dec 2020 $226M | $731M | $131M – $2.6B | $647M (-11%) | $316M | 50% | 49 | up | D | |
| 40 | Tech Companies · led at Seed, 2024 | Series B Jul 2026 $50M | $401M | $232M – $806M | $529M (+32%) | $58.2M | 0% | 142 | growing | C | |
| 41 | Tech Companies · led at Series B, 2015 | Series E Oct 2025 $75M | $2.7B | $1.7B – $3.1B | $2.7B (0%) | $324M | 0% | 905 | up | A | |
| 42 | Health Care Services · since Growth, 2023 | Growth Equity Oct 2023 $315M | $2.7B | $531M – $6.2B | $2.5B (-10%) | $376M | 10% | 378 | flat | D | |
| 43 | Tech Companies · since Series C, 2020 | Series E Mar 2021 $220M | $2.0B | $330M – $5.4B | $1.9B (-8%) | $601M | 41% | 752 | flat | D | |
| 44 | Tech Companies · led at Series C, 2021 | Series C Nov 2021 $200M | $430M | $149M – $2.5B | $427M (-1%) | $245M | 91% | 303 | down | D | |
| 45 | Tech Companies · since Series A, 2014 | Debt Aug 2022 $100M | $380M | $79.9M – $1.3B | $335M (-12%) | $139M | 59% | 383 | down | D | |
| 46 | Drug Stores & Pharmacies · led at Series C, 2020 | Series D Oct 2021 $142M | $231M | $113M – $676M | $231M (0%) | $187M | 97% | 313 | shrinking | C | |
| 47 | Psychiatrists & Psychiatric Hospitals · led at Series A, 2015 | Growth Equity Jan 2022 $60M | $255M | $36.5M – $961M | $253M (-1%) | $68.8M | 42% | 57 | flat | D | |
| 48 | Payment Processing & Point of Sale · led at Seed, 2020 | Series B Jan 2025 $90M | $1.2B | $460M – $1.4B | $1.2B (0%) | $131M | 0% | 169 | flat | B | |
| 49 | Biotechnology · since Series D, 2019 | Series D Dec 2019 $125M | $164M | $88.2M – $427M | $164M (0%) | $179M | 97% | – | shrinking | C | |
| 50 | Home Health Care · since Growth, 2024 | Growth Equity Jul 2024 $200M | $2.6B | $727M – $4.0B | $2.2B (-17%) | $238M | 0% | 815 | flat | C |
Valuation: VCMC's valuation with its range, from a low to a high scenario; a company with no valuation shows a dash, one acquired after its last round its last value as a private company.
Activity
How Oak HC/FT invests: stages, industries and countries
Most of its rounds are Series C and later (39%). Its companies span 29 industries, most in Tech Companies, Payment Processing & Point of Sale and Health Care Services, across 15 countries.
Rounds by stage
- Seed 17
- Series A 30
- Series B 42
- Series C and later 58
Investments by industry
- Tech Companies 43
- Payment Processing & Point of Sale 9
- Health Care Services 8
- Home Health Care 5
- Software Development Services 5
- Insurance - Agents, Carriers & Brokers 4
- Clinics - Surgeons & Physicians 3
- Biotechnology 2
Investments by country
- United States 80
- Canada 4
- Israel 4
- Mexico 3
- Chile 2
- Colombia 2
Recent rounds
Oak HC/FT's latest investments
Oak HC/FT's most recent funding rounds, newest first. 13 rounds in the last 12 months.
- Series A, led $31M 6 Oct 2026
- Series A, led $30M 1 Oct 2026
- Series A, led $35M 9 Sep 2026
- Series A, led $35M 9 Sep 2026
- Series C $100M 19 Aug 2026
- Series A, led $30M 3 Aug 2026
- Series D $120M 22 Jul 2026
- Seed, led $33M 13 Jul 2026
- Series B $50M 9 Jul 2026
- Series A, led $200M 3 Jun 2026
Co-investors
Oak HC/FT's top co-investors
The investors that most often join the same rounds as Oak HC/FT. General Catalyst leads, with 14 rounds together.
- General Catalyst 14 rounds together
- Y Combinator 11 rounds together
- Andreessen Horowitz 11 rounds together
- Sequoia Capital 9 rounds together
- 8 rounds together
- 7 rounds together
- 6 rounds together
- WestCap 6 rounds together
- GV 6 rounds together
- QED Investors 5 rounds together
About
About Oak HC/FT
Oak HC/FT Management Company, LLC is an American private investment firm engaged in growth equity investments in the healthcare and fintech sectors. The company provides venture and growth equity financing to companies at various stages, including seed and growth, and supports portfolio companies in their development. Oak HC/FT operates from offices in Stamford, Connecticut, and San Francisco, California.
Description from Veridion's company data.
- Founded
- 2014
- Based in
- Stamford, United States
- Team
- 56 people, +6% in a year
- Type
- Venture capital firm
Focus markets
- Healthcare
- Fintech
What Oak HC/FT offers
- Healthcare Growth Equity Investment
- Fintech Growth Equity Investment
- Healthcare Portfolio Company Development
- Fintech Portfolio Company Development
- Healthcare System Structural Change Consulting
- Fintech System Structural Change Consulting
- Healthcare Investment Strategy Consulting
- Fintech Investment Strategy Consulting
Questions
Oak HC/FT: frequently asked questions
How many companies has Oak HC/FT invested in?
106 venture-backed companies on VCMC, across 147 funding rounds.
What are Oak HC/FT's most valuable private companies?
Devoted Health ($18.0B), Rapyd ($4.8B), Olive ($3.6B), by VCMC's valuation.
What was Oak HC/FT's latest investment?
Vitalize, a Series A round in Oct 2026 of $31M, which Oak HC/FT led.
Which stages does Oak HC/FT invest in?
Oak HC/FT invests most often at Series C and later (58 rounds), followed by Series B (42) and Series A (30). It has also joined 17 seed rounds.
What is Oak HC/FT's portfolio worth?
Its private companies with a VCMC valuation are worth $87.2B together. That is the sum of the companies' values, not what Oak HC/FT owns.
Who does Oak HC/FT invest alongside?
General Catalyst (14 rounds), Y Combinator (11 rounds), Andreessen Horowitz (11 rounds).